GLENMARK PHARMACEUTICALS LIMITED

Analyst Reco. Glenmark Pharmaceuticals Limited

Equities

GLENMARK

INE935A01035

Market Closed - NSE India S.E. Other stock markets 05:13:47 26/04/2024 pm IST			5-day change	1st Jan Change
1,079 ^INR	-0.09%		+5.16%	+26.39%

25/04	Glenmark Lifesciences' Net Profit Slides in Fiscal Q4	MT
01/04	Glenmark Pharmaceuticals Limited Announces Board Changes	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nomura Adjusts Glenmark Pharmaceuticals’ Price Target to INR909 From INR841, Keeps at Neutral	20/02	MT
Indian shares set to open higher ahead of national budget	01/02	RE
Nomura Downgrades Glenmark Pharmaceuticals to Neutral From Buy, Adjusts Price Target to INR841 From INR633	26/23/26	MT
INDIA STOCKS-India's Sensex logs worst week in 15 months on rate worries	22/23/22	RE
Indian Equities Close Flat, Weighed Down by Worries Over US Rate Hikes, Weak Chinese Economy	22/23/22	MT
Nomura Adjusts Glenmark Pharmaceuticals' Price Target to INR633 From INR580, Keeps at Buy	14/23/14	MT
Nomura Adjusts Glenmark Pharmaceuticals' Price Target to 580 Indian Rupees From 757 Rupees, Keeps at Buy	30/22/30	MT
Indian shares may open higher, tracking Asia	27/22/27	RE
Crisil Keeps AA- Rating on Glenmark Pharmaceuticals; Raises Outlook to Positive	24/21/24	MT
S&P Raises Glenmark Pharmaceuticals' Rating to BB on Plan to Cut Debt	19/21/19	MT
GLENMARK PHARMACEUTICALS : Nomura Adjusts Glenmark Pharmaceuticals' Price Target to 757 Indian Rupees From 762 Indian Rupees, Keeps at Buy	24/21/24	MT
GLENMARK PHARMACEUTICALS : Nomura Adjusts Glenmark Pharmaceuticals' Price Target to 762 Indian Rupees From 727 Indian Rupees, Keeps at Buy	18/21/18	MT
Glenmark Pharmaceuticals : S&P Global Maintains Glenmark Pharmaceuticals' BB- Issuer Credit Rating; Outlook Stable	25/20/25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer